Evaluation of circulating tumor DNA (ctDNA) with respect to germline alterations in metastatic castrate resistant prostate cancer patients.

Authors

null

Peter Steinwald

Tulane University School of Medicine, New Orleans, LA

Peter Steinwald , Lynne Chapman , Bryce Raymon Christensen , Leta Ko , James Vu , Joshua Schiff , Lahiru Ranasinghe , Marcus Marie Moses , Patrick Cotogno , Charlotte Manogue , Jodi Lyn Layton , Brian E. Lewis , A. Oliver Sartor , Elisa Ledet

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 254)

DOI

10.1200/JCO.2019.37.7_suppl.254

Abstract #

254

Poster Bd #

L11

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.

Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.

First Author: Alexandra Androsova

Poster

2021 ASCO Annual Meeting

Circulating tumor DNA-based genomic profiling of small bowel adenocarcinoma.

Circulating tumor DNA-based genomic profiling of small bowel adenocarcinoma.

First Author: Pat Gulhati

Poster

2023 ASCO Genitourinary Cancers Symposium

Genomic alterations in patients with prostate cancer with liver metastases.

Genomic alterations in patients with prostate cancer with liver metastases.

First Author: Crystal Casado

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Circulating tumor DNA–based genomic landscape of <em>KRAS</em> wild-type pancreatic adenocarcinoma.

Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.

First Author: Brendon Fusco